| Dr Malcolm A Paine, MD | |
|
140 Hospital Dr, Suite 302, Bennington, VT 05201-5009 | |
| (802) 442-9600 | |
| Not Available |
| Full Name | Dr Malcolm A Paine |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 28 Years |
| Location | 140 Hospital Dr, Bennington, Vermont |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851555437 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | RT-1865 (New Hampshire) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Southwestern Vermont Medical Center | Bennington, VT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southwestern Vermont Medical Center Inc | 0143138446 | 142 |
News Archive
Mordor Intelligence releases their report on the Global Pharmaceutical Contract Manufacturing market is segmented by Dose Formulation type (Solid Dose Formulation, Liquid Dose Formulation, Injectable Dose Formulation - By Geographical Region (North America, Europe, Latin America, APAC, Middle East & Africa) - Drivers, Restraints, Vendor Profiles, Global Market Size, Forecasts & Analysis (2015-2020).
New findings from a 15-year series of studies led by care providers at Scripps Whittier Diabetes Institute reveal that culturally tailored community-created programs are effective at reducing health-related costs and delivering higher quality care.
A multicentre Phase II trial of intravenous artesunate will begin recruitment of patients in September.
Peplin, Inc. (ASX:PLI) today announced completion of enrolment in its second Phase 3 clinical trial for the use of PEP005 (ingenol mebutate) Gel to treat actinic (solar) keratoses (AK), a common pre-cancerous skin lesion, on non-head treatment areas, which include the trunk and extremities. This completes enrolment in the final of four pivotal trials planned for the submission of the New Drug Application (NDA) for AK.
› Verified 5 days ago
| Entity Name | Southwestern Vermont Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184994162 PECOS PAC ID: 0143138446 Enrollment ID: O20120613000217 |
News Archive
Mordor Intelligence releases their report on the Global Pharmaceutical Contract Manufacturing market is segmented by Dose Formulation type (Solid Dose Formulation, Liquid Dose Formulation, Injectable Dose Formulation - By Geographical Region (North America, Europe, Latin America, APAC, Middle East & Africa) - Drivers, Restraints, Vendor Profiles, Global Market Size, Forecasts & Analysis (2015-2020).
New findings from a 15-year series of studies led by care providers at Scripps Whittier Diabetes Institute reveal that culturally tailored community-created programs are effective at reducing health-related costs and delivering higher quality care.
A multicentre Phase II trial of intravenous artesunate will begin recruitment of patients in September.
Peplin, Inc. (ASX:PLI) today announced completion of enrolment in its second Phase 3 clinical trial for the use of PEP005 (ingenol mebutate) Gel to treat actinic (solar) keratoses (AK), a common pre-cancerous skin lesion, on non-head treatment areas, which include the trunk and extremities. This completes enrolment in the final of four pivotal trials planned for the submission of the New Drug Application (NDA) for AK.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Malcolm A Paine, MD 140 Hospital Dr, Suite 302, Bennington, VT 05201-5009 Ph: (802) 442-9600 | Dr Malcolm A Paine, MD 140 Hospital Dr, Suite 302, Bennington, VT 05201-5009 Ph: (802) 442-9600 |
News Archive
Mordor Intelligence releases their report on the Global Pharmaceutical Contract Manufacturing market is segmented by Dose Formulation type (Solid Dose Formulation, Liquid Dose Formulation, Injectable Dose Formulation - By Geographical Region (North America, Europe, Latin America, APAC, Middle East & Africa) - Drivers, Restraints, Vendor Profiles, Global Market Size, Forecasts & Analysis (2015-2020).
New findings from a 15-year series of studies led by care providers at Scripps Whittier Diabetes Institute reveal that culturally tailored community-created programs are effective at reducing health-related costs and delivering higher quality care.
A multicentre Phase II trial of intravenous artesunate will begin recruitment of patients in September.
Peplin, Inc. (ASX:PLI) today announced completion of enrolment in its second Phase 3 clinical trial for the use of PEP005 (ingenol mebutate) Gel to treat actinic (solar) keratoses (AK), a common pre-cancerous skin lesion, on non-head treatment areas, which include the trunk and extremities. This completes enrolment in the final of four pivotal trials planned for the submission of the New Drug Application (NDA) for AK.
› Verified 5 days ago
Dr. John Matheson Mclellan, MDCM Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 140 Hospital Dr, Bennington, VT 05201 Phone: 802-442-8182 | |
Dr. Kimberley Jayne Sampson, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 140 Hospital Dr, Bennington, VT 05201 Phone: 802-442-9600 | |
Michael Silverberg, DO Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 140 Hospital Dr Ste 302, Bennington, VT 05201 Phone: 802-442-9600 | |
Sarah Perkins Dahl, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 345 Elm St, Bennington, VT 05201 Phone: 802-447-7591 Fax: 802-447-2838 | |
Dr. Themarge Mclellan Small, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 140 Hospital Dr, Suite 302, Bennington, VT 05201 Phone: 802-442-9600 |